Asia Pacific Pharmaceutical announced that it intends to repurchase the company's shares at no less than RMB 10 million and not more than RMB 20 million. The repurchase price will not exceed RMB 7 yuan/share. Repurchases of shares will be used to implement equity incentives or employee stock ownership plans. If the company fails to carry out the aforementioned use within three years after the share repurchase is completed, the unused repurchased shares will be cancelled in accordance with law. The sources of repurchase funds are the company's own funds and self-raised funds.

Asia Pacific Pharmaceutical announced that it intends to repurchase the company's shares at no less than RMB 10 million and not more than RMB 20 million. The repurchase price will not exceed RMB 7 yuan/share. Repurchases of shares will be used to implement equity incentives or employee stock ownership plans. If the company fails to carry out the aforementioned use within three years after the share repurchase is completed, the unused repurchased shares will be cancelled in accordance with law. The sources of repurchase funds are the company's own funds and self-raised funds.